109
Views
62
CrossRef citations to date
0
Altmetric
Article

Bone mineral density in patients with inflammatory bowel disease: A population‐based prospective two‐year follow‐up study

, , &
Pages 145-153 | Received 16 Jun 2003, Accepted 15 Oct 2003, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Signe Larsen, Klaus Bendtzen & Ole Haagen Nielsen. (2010) Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management. Annals of Medicine 42:2, pages 97-114.
Read now
Ida B. Gottschalck, Palle B. Jeppesen, Bolette Hartmann, Jens J. Holst & Dennis B. Henriksen. (2008) Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome. Scandinavian Journal of Gastroenterology 43:11, pages 1304-1310.
Read now
R. A Van Hogezand & N. A. T. Hamdy. (2006) Skeletal morbidity in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 41:sup243, pages 59-64.
Read now
A. Rispo, R. Scarpa, E. Di Girolamo, A. Cozzolino, G. Lembo, M. Atteno, T. De Falco, M. Lo Presti & F. Castiglione. (2005) Infliximab in the treatment of extra‐intestinal manifestations of Crohn's disease. Scandinavian Journal of Rheumatology 34:5, pages 387-391.
Read now

Articles from other publishers (58)

Shaofeng Wu, Zhen Ye, Yi Yan, Xinli Zhan, Liang Ren, Chenxing Zhou, Tianyou Chen, Yuanlin Yao, Jichong Zhu, Siling Wu, Fengzhi Ma, Lu Liu, Binguang Fan & Chong Liu. (2023) The causal relationship between autoimmune diseases and osteoporosis: a study based on Mendelian randomization. Frontiers in Endocrinology 14.
Crossref
Edyta Maria Tulewicz-Marti, Konrad Lewandowski & Grażyna Rydzewska. (2022) Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine 11:14, pages 4138.
Crossref
Alireza Sharifi, Mehdi Kashani, Ahmad Salimzadeh, Mahdi Ebrahimi & Mehrad Nasiri Savadkouhi. (2021) Decreased bone mineral density, Vitamin K and Vitamin D in ulcerative colitis patients. Medicina Clínica Práctica 4:4, pages 100276.
Crossref
Fashuai Wu, Yu Huang, Jialu Hu & Zengwu Shao. (2020) Mendelian randomization study of inflammatory bowel disease and bone mineral density. BMC Medicine 18:1.
Crossref
Sofia Kärnsund, Bobby Lo, Flemming Bendtsen, Jakob Holm & Johan Burisch. (2020) Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease. World Journal of Gastroenterology 26:35, pages 5362-5374.
Crossref
Mohammed Ewid, Nawaf Al Mutiri, Khalid Al Omar, Amal N Shamsan, Awais A Rathore, Nazmus Saquib, Anas Salaas, Omar Al Sarraj, Yaman Nasri, Ahmed Attal, Abdulrahman Tawfiq & Hossam Sherif. (2020) Updated bone mineral density status in Saudi patients with inflammatory bowel disease. World Journal of Gastroenterology 26:35, pages 5343-5353.
Crossref
Bobby Lo, Jakob Præst Holm, Marianne Kajbæk Vester-Andersen, Flemming Bendtsen, Ida Vind & Johan Burisch. (2020) Incidence, Risk Factors and Evaluation of Osteoporosis in Patients With Inflammatory Bowel Disease: A Danish Population-Based Inception Cohort With 10 Years of Follow-Up. Journal of Crohn's and Colitis 14:7, pages 904-914.
Crossref
Yael Levy‐Shraga, Anatoly Shenkar, Dalit Modan‐Moses, Amit Assa, Yael Haberman, Dror Shouval, Anat Guz‐Mark, Avishay Lahad & Batia Weiss. (2019) Longitudinal changes in bone mineral density in children with inflammatory bowel diseases. Acta Paediatrica 109:5, pages 1026-1032.
Crossref
Dolores Sgambato, Francesca Gimigliano, Cristiana De Musis, Antimo Moretti, Giuseppe Toro, Emanuele Ferrante, Agnese Miranda, Domenico De Mauro, Lorenzo Romano, Giovanni Iolascon & Marco Romano. (2019) Bone alterations in inflammatory bowel diseases. World Journal of Clinical Cases 7:15, pages 1908-1925.
Crossref
Neveen A. T. Hamdy & Natasha M. Appelman‐Dijkstra. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 510 516 .
Solvey Schüle, Jean-Benoît Rossel, Diana Frey, Luc Biedermann, Michael Scharl, Jonas Zeitz, Natália Freitas-Queiroz, Thomas Kuntzen, Thomas Greuter, Stephan R. Vavricka, Gerhard Rogler & Benjamin Misselwitz. (2017) Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study. Medicine 96:22, pages e6788.
Crossref
Anat Guz-Mark, Firas Rinawi, Oxana Egotubov, Ilan Shimon, Raanan Shamir & Amit Assa. (2017) Pediatric-onset inflammatory bowel disease poses risk for low bone mineral density at early adulthood. Digestive and Liver Disease 49:6, pages 639-642.
Crossref
Solvey Schüle, Jean‐Benoît Rossel, Diana Frey, Luc Biedermann, Michael Scharl, Jonas Zeitz, Natália Freitas‐Queiroz, Valérie Pittet, Stephan R Vavricka, Gerhard Rogler & Benjamin Misselwitz. (2016) Prediction of low bone mineral density in patients with inflammatory bowel diseases. United European Gastroenterology Journal 4:5, pages 669-676.
Crossref
. 2016. Outpatient Nutrition Care and Home Nutrition Support. Outpatient Nutrition Care and Home Nutrition Support 43 55 .
Elke Wintermeyer, Christoph Ihle, Sabrina Ehnert, Ulrich Stöckle, Gunnar Ochs, Peter de Zwart, Ingo Flesch, Christian Bahrs & Andreas Nussler. (2016) Crucial Role of Vitamin D in the Musculoskeletal System. Nutrients 8:6, pages 319.
Crossref
Yasuyo Wada, Tadakazu Hisamatsu, Makoto Naganuma, Katsuyoshi Matsuoka, Susumu Okamoto, Nagamu Inoue, Tomoharu Yajima, Keisuke Kouyama, Yasushi Iwao, Haruhiko Ogata, Toshifumi Hibi, Takayuki Abe & Takanori Kanai. (2015) Risk factors for decreased bone mineral density in inflammatory bowel disease: A cross-sectional study. Clinical Nutrition 34:6, pages 1202-1209.
Crossref
Kristoffer Dahl, Luai Awad Ahmed, Ragnar Martin Joakimsen, Lone Jørgensen, Anne Elise Eggen, Erik Fink Eriksen & Åshild Bjørnerem. (2015) High-sensitivity C-reactive protein is an independent risk factor for non-vertebral fractures in women and men: The Tromsø Study. Bone 72, pages 65-70.
Crossref
Myriam Cheikh, Taieb Jomni, Wassila Bougassas, Lamia Ben Yaghlène & Mohamed Hedi Douggui. (2015) Bone Mineral Density in Patients with Newly Diagnosed Inflammatory Bowel Disease: Frequency and Risk Factors in Tunisian Population. Results of a Prospective Study. Open Journal of Rheumatology and Autoimmune Diseases 05:04, pages 126-130.
Crossref
Ad A van Bodegraven, Nathalie Bravenboer, Birgit I Witte, Gerard Dijkstra, C Janneke van der Woude, Pieter C M Stokkers, Maurice G Russel, Bas Oldenburg, Marieke Pierik, Jan C Roos, Ruud A van Hogezand, Vincent K Dik, Angela E Oostlander, J Coen Netelenbos, Lex van de Langerijt, Daniel W Hommes & Paul Lips. (2014) Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation. Gut 63:9, pages 1424-1430.
Crossref
Bincy P. Abraham, Preethi Prasad & Hoda M. Malaty. (2014) Vitamin D Deficiency and Corticosteroid Use Are Risk Factors for Low Bone Mineral Density in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences 59:8, pages 1878-1884.
Crossref
Laura E. Targownik, Charles N. Bernstein & William D. Leslie. (2014) Risk factors and management of osteoporosis in inflammatory bowel disease. Current Opinion in Gastroenterology 30:2, pages 168-174.
Crossref
Marco Gasparetto. (2014) Crohn's disease and growth deficiency in children and adolescents. World Journal of Gastroenterology 20:37, pages 13219.
Crossref
Lily Nahidi, Andrew S. Day, Daniel A. Lemberg & Steven T. Leach. (2014) Paediatric Inflammatory Bowel Disease: A Mechanistic Approach to Investigate Exclusive Enteral Nutrition Treatment. Scientifica 2014, pages 1-9.
Crossref
María Dolores Ballesteros Pomar, Alfonso Vidal Casariego & Isidoro Cano Rodríguez. 2014. El hueso en las enfermedades endocrinas y nutricionales. El hueso en las enfermedades endocrinas y nutricionales 269 281 .
Neveen A.T. Hamdy. 2013. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 489 494 .
Ida Hilmi, K. Sunderesvaran, Vijay Ananda, S. A. Sarji, Kulenthran Arumugam & K. L. Goh. (2013) Increased Fracture Risk and Osteoporosis Not Associated With Vitamin D Levels in Malaysian Patients With Inflammatory Bowel Disease. The Journal of Clinical Endocrinology & Metabolism 98:6, pages 2415-2421.
Crossref
Sjoerd F. Bakker, Vincent K. Dik, Birgit I. Witte, Paul Lips, Jan C. Roos & Adriaan A. Van Bodegraven. (2013) Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation. Journal of Crohn's and Colitis 7:5, pages 377-384.
Crossref
Neville Azzopardi & Pierre Ellul. (2013) Risk Factors for Osteoporosis in Crohnʼs Disease. Inflammatory Bowel Diseases 19:6, pages 1173-1178.
Crossref
Laura E Targownik, Charles N Bernstein, Zoann Nugent, Helena Johansson, Anders Oden, Eugene McCloskey, John A Kanis & William D Leslie. (2013) Inflammatory bowel disease and the risk of fracture after controlling for FRAX. Journal of Bone and Mineral Research 28:5, pages 1007-1013.
Crossref
Amanda J. Salacinski, Miguel D. Regueiro, Craig E. Broeder & Jean L. McCrory. (2012) Decreased Neuromuscular Function in Crohn’s Disease Patients Is Not Associated with Low Serum Vitamin D Levels. Digestive Diseases and Sciences 58:2, pages 526-533.
Crossref
Laura E. Targownik, William D. Leslie, Rachel Carr, Ian Clara, Norine Miller, Linda Rogala, Lesley A. Graff, John R. Walker & Charles N. Bernstein. (2012) Longitudinal Change in Bone Mineral Density in a Population-Based Cohort of Patients with Inflammatory Bowel Disease. Calcified Tissue International 91:5, pages 356-363.
Crossref
Isaac Soo, Jesse Siffledeen, Kerry Siminoski, Bob McQueen & Richard N. Fedorak. (2012) Risedronate improves bone mineral density in Crohn's disease: A two year randomized controlled clinical trial. Journal of Crohn's and Colitis 6:7, pages 777-786.
Crossref
Rebeca Reyes García, Esteban Jódar Gimeno, Antonia García Martín, Manuel Romero Muñoz, José Manuel Gómez Sáez, Inés Luque Fernández, Mariela Varsavsky, Sonsoles Guadalix Iglesias, Isidoro Cano Rodriguez, María Dolores Ballesteros Pomar, Alfonso Vidal Casariego, Pedro Rozas Moreno, María Cortés Berdonces, Diego Fernández García, Amparo Calleja Canelas, Mercedes Palma Moya, Guillermo Martínez Díaz-Guerra, José J. Jimenez Moleón & Manuel Muñoz Torres. (2012) Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales. Endocrinología y Nutrición 59:3, pages 174-196.
Crossref
Rebeca Reyes García, Esteban Jódar Gimeno, Antonia García Martín, Manuel Romero Muñoz, José Manuel Gómez Sáez, Inés Luque Fernández, Mariela Varsavsky, Sonsoles Guadalix Iglesias, Isidoro Cano Rodriguez, María Dolores Ballesteros Pomar, Alfonso Vidal Casariego, Pedro Rozas Moreno, María Cortés Berdonces, Diego Fernández García, Amparo Calleja Canelas, Mercedes Palma Moya, Guillermo Martínez Díaz-Guerra, José J. Jimenez Moleón & Manuel Muñoz Torres. (2012) Clinical practice guidelines for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Endocrinología y Nutrición (English Edition) 59:3, pages 174-196.
Crossref
A.-L. Pelletier & G. Hayem. (2012) Manifestations osseuses et articulaires au cours des maladies inflammatoires chroniques intestinales. EMC - Gastro-entérologie 7:1, pages 1-6.
Crossref
Gülfem Kaya, Erdem Koçak, Erdem Akbal, Adnan Taş & Seyfettin Köklü. (2011) Comparison of the Possible Risk Factors of Bone Mineral Density in Subjects with Ulcerative Colitis and Healthy Subjects. Southern Medical Journal 104:11, pages 747-751.
Crossref
Rebecca J. Hill, Denise S.K. Brookes & Peter S.W. Davies. (2011) Bones in pediatric Crohnʼs disease. Inflammatory Bowel Diseases 17:5, pages 1223-1228.
Crossref
Pál Miheller, Péter L. Lakatos & Miklós Tóth. (2010) Bone Homeostasis in Intestinal Disorders. Clinical Reviews in Bone and Mineral Metabolism 8:3, pages 140-148.
Crossref
Gaurav Arora, Gurkirpal Singh, Shweta Vadhavkar, Shamita B. Shah, Ajitha Mannalithara, Alka Mithal & George Triadafilopoulos. (2010) Incidence and Risk of Intestinal and Extra-intestinal Complications in Medicaid Patients with Inflammatory Bowel Disease: A 5-Year Population-Based Study. Digestive Diseases and Sciences 55:6, pages 1689-1695.
Crossref
Charles N. Bernstein & William D. Leslie. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease 665 677 .
S Poturoglu, F Balkan, ZE Karaali, D Ibrisim, S Yanmaz, MB Aktuglu, T Alioglu & M Kendir. (2010) Relationship between Bone Mineral Density and Clinical Features in Patients with Inflammatory Bowel Disease: A Local Study in Turkish Population. Journal of International Medical Research 38:1, pages 62-68.
Crossref
Wojciech Pluskiewicz, Jerzy Zdrzałek & Dariusz Karasek. (2009) Spine bone mineral density and VDR polymorphism in subjects with ulcerative colitis. Journal of Bone and Mineral Metabolism 27:5, pages 567-573.
Crossref
Alfredo José Lucendo & Livia Cristina De Rezende. (2009) Importance of nutrition in inflammatory bowel disease. World Journal of Gastroenterology 15:17, pages 2081.
Crossref
Neveen A. T. Hamdy. 2008. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 276 279 .
Gilad Hamdani, Yankel Gabet, Daniel Rachmilewitz, Fanny Karmeli, Itai Bab & Rivka Dresner-Pollak. (2008) Dextran sodium sulfate-induced colitis causes rapid bone loss in mice. Bone 43:5, pages 945-950.
Crossref
Max Reinshagen. (2008) Osteoporosis in inflammatory bowel disease. Journal of Crohn's and Colitis 2:3, pages 202-207.
Crossref
Charles N. Bernstein. (2006) Inflammatory bowel diseases as secondary causes of osteoporosis. Current Osteoporosis Reports 4:3, pages 116-123.
Crossref
Charles N. Bernstein. (2006) Inflammatory bowel diseases as secondary causes of osteoporosis. Current Osteoporosis Reports 4:3, pages 116-123.
Crossref
Gary R. Lichtenstein, Bruce E. Sands & Michael Pazianas. (2006) Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflammatory Bowel Diseases 12:8, pages 797-813.
Crossref
Hans-Joachim Mentzel, Joerg Blume, Joachim Boettcher, Gabriele Lehmann, Diana Tuchscherer, Alexander Pfeil, Anika Kramer, Ansgar Malich, Eberhard Kauf, Gert Hein & Werner A. Kaiser. (2006) The potential of digital X-ray radiogrammetry (DXR) in the assessment of osteopenia in children with chronic inflammatory bowel disease. Pediatric Radiology 36:5, pages 415-420.
Crossref
R. A. van Hogezand, D. Bänffer, A. H. Zwinderman, E. V. McCloskey, G. Griffioen & N. A. T. Hamdy. (2006) Ileum resection is the most predictive factor for osteoporosis in patients with Crohn’s disease. Osteoporosis International 17:4, pages 535-542.
Crossref
Katja S Rothfuss, Eduard F Stange & Klaus R Herrlinger. (2006) Extraintestinal manifestations and complications in inflammatory bowel diseases. World Journal of Gastroenterology 12:30, pages 4819.
Crossref
Naomi Lee, Graham Radford-SmithDr.Dr. & Dennis R Taaffe. (2005) Bone Loss in Crohnʼs Disease: Exercise As a Potential Countermeasure. Inflammatory Bowel Diseases 11:12, pages 1108-1118.
Crossref
A. Wiercinska-Drapalo, J. Jaroszewicz, E. Tarasow, R. Flisiak & D. Prokopowicz. (2005) Transforming growth factor beta(1) and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients. Prostaglandins & Other Lipid Mediators 78:1-4, pages 160-168.
Crossref
Charles N Bernstein & William D Leslie. (2005) Therapy Insight: osteoporosis in inflammatory bowel disease—advances and retreats. Nature Clinical Practice Gastroenterology & Hepatology 2:5, pages 232-239.
Crossref
Yong-Bing Cao. (2005) Effects of Changtai granules, a traditional compound Chinese medicine, on chronic trinitrobenzene sulfonic acid-induced colitis in rats. World Journal of Gastroenterology 11:23, pages 3539.
Crossref
F. Retornaz, V. Seux & J. Soubeyrand. (2004) Ostéoporoses secondaires en médecine interne. La Revue de Médecine Interne 25, pages S543-S551.
Crossref
Edward V. LoftusJrJr. (2004) Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Current Gastroenterology Reports 6:6, pages 506-513.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.